![Laura Unnasch](/sites/default/files/styles/medium/public/2022-10/amy-pic-3-bw-200x200.jpg?itok=d2hHI7mL)
Latest News Story Headlines
Alnylam Reports Positive Topline Results from HELIOS-B Phase 3 Study of Vutrisiran, Achieving Statistical Significance on Primary and All Secondary Endpoints in Both Overall and Monotherapy Populations
Jun 24, 2024
2024 Spring Newsletter
Catch up on the latest happenings in our spring newsletter.
Calendar & Upcoming Events
There are no upcoming scheduled events at the moment in next 30 days.
Sign Up for the Latest Updates
Get news from Amyloidosis Foundation
in your inbox
By submitting this form, you are consenting to receive marketing emails from : Amyloidosis Foundation, 7151 N. Main St., Suite 2, Clarkston, MI, 48346, US, https://www.amyloidosis.org. You can revoke your consent to receive emails at any time by using SafeUnsubscribe© link, found at the bottom of every email. Emails are serviced by Constant Contract.